Figure 9.NPAS2 was associated with prognosis in LUAD. (A, B) NPAS2 expression levels between tumor and normal sample in TCGA; (C–E) High-expressed NPAS2 was associated with poor OS, PFS and LRS in LUAD based on TCGA; (F–H) NPAS2 expression increased with advanced stage. (I–K) High-expressed NPAS2 was associated with poor PFS, LRS and DMFS of LUAD patients in an independent cohort.
